Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Poddubskaya

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Cancer Informatics|April 3, 2019
High-Throughput Mutation Data Now Complement Transcriptomic Profiling: Advances in Molecular Pathway Activation Analysis Approach in Cancer BiologyAnton Buzdin, Maxim Sorokin, Elena Poddubskaya, et al.
Frontiers in Bioscience (Landmark Edition)|June 4, 2025
Role of ERK1/2 and p38 Protein Kinases in Tumors: Biological Insights and Clinical ImplicationsAleksandra Emelyanova, Alexander Modestov, Anton Buzdin, et al.
International Journal of Molecular Sciences|October 29, 2025
Regulatory Mechanisms and Functional Roles of Readthrough Transcripts in TumorigenesisAlexander Modestov, Galina Zakharova, Elena Poddubskaya, et al.
Biochemistry. Biokhimiia|January 26, 2025
Activation of P38 MAPK Signaling Cascade is Linked with Clinical Outcomes and Therapeutic Responses in Human CancersAleksandra Emelyanova, Marianna Zolotovskaia, Elena Poddubskaya, et al.
Biochemistry. Biokhimiia|June 4, 2024
Sample-Wise and Gene-Wise Comparisons Confirm a Greater Similarity of RNA and Protein Expression Data at the Level of Molecular Pathways and Suggest an Approach for the Data Quality Check in High-Throughput Expression DatabasesMikhail Raevskiy, Maxim Sorokin, Aleksandra Emelianova, et al.
Biomedicines|August 26, 2022
Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3' Oncogenes from FFPE Bulk RNA Sequencing DataElizaveta Rabushko, Maxim Sorokin, Maria Suntsova, et al.
Frontiers in Molecular Biosciences|December 10, 2021
Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite InstabilityMaksim Sorokin, Elizaveta Rabushko, Victor Efimov, et al.
International Journal of Molecular Sciences|March 28, 2026
Molecular Context of ADAR-Mediated Editing of Coding RNA in Colorectal and Lung CancersAlexander Modestov, Daniil Luppov, Ivan Gaziev, et al.
Biomedicines|May 14, 2020
RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer SpecimensMaxim Sorokin, Kirill Ignatev, Elena Poddubskaya, et al.
Frontiers in Oncology|November 5, 2019
Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK InhibitorsElena Poddubskaya, Alexey Bondarenko, Alexander Boroda, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cancer Informatics|April 3, 2019
High-Throughput Mutation Data Now Complement Transcriptomic Profiling: Advances in Molecular Pathway Activation Analysis Approach in Cancer BiologyAnton Buzdin, Maxim Sorokin, Elena Poddubskaya, et al.
Frontiers in Bioscience (Landmark Edition)|June 4, 2025
Role of ERK1/2 and p38 Protein Kinases in Tumors: Biological Insights and Clinical ImplicationsAleksandra Emelyanova, Alexander Modestov, Anton Buzdin, et al.
International Journal of Molecular Sciences|October 29, 2025
Regulatory Mechanisms and Functional Roles of Readthrough Transcripts in TumorigenesisAlexander Modestov, Galina Zakharova, Elena Poddubskaya, et al.
Biochemistry. Biokhimiia|January 26, 2025
Activation of P38 MAPK Signaling Cascade is Linked with Clinical Outcomes and Therapeutic Responses in Human CancersAleksandra Emelyanova, Marianna Zolotovskaia, Elena Poddubskaya, et al.
Biochemistry. Biokhimiia|June 4, 2024
Sample-Wise and Gene-Wise Comparisons Confirm a Greater Similarity of RNA and Protein Expression Data at the Level of Molecular Pathways and Suggest an Approach for the Data Quality Check in High-Throughput Expression DatabasesMikhail Raevskiy, Maxim Sorokin, Aleksandra Emelianova, et al.
Biomedicines|August 26, 2022
Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3' Oncogenes from FFPE Bulk RNA Sequencing DataElizaveta Rabushko, Maxim Sorokin, Maria Suntsova, et al.
Frontiers in Molecular Biosciences|December 10, 2021
Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite InstabilityMaksim Sorokin, Elizaveta Rabushko, Victor Efimov, et al.
International Journal of Molecular Sciences|March 28, 2026
Molecular Context of ADAR-Mediated Editing of Coding RNA in Colorectal and Lung CancersAlexander Modestov, Daniil Luppov, Ivan Gaziev, et al.
Biomedicines|May 14, 2020
RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer SpecimensMaxim Sorokin, Kirill Ignatev, Elena Poddubskaya, et al.
Frontiers in Oncology|November 5, 2019
Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK InhibitorsElena Poddubskaya, Alexey Bondarenko, Alexander Boroda, et al.
Pageof 5